Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
2.910
+0.130 (4.68%)
At close: Dec 20, 2024, 4:00 PM
3.070
+0.160 (5.50%)
After-hours: Dec 20, 2024, 6:00 PM EST
Leap Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 62.82 | 70.64 | 65.5 | 114.92 | 52.07 | 3.89 | Upgrade
|
| Cash & Short-Term Investments | 62.82 | 70.64 | 65.5 | 114.92 | 52.07 | 3.89 | Upgrade
|
| Cash Growth | -22.19% | 7.85% | -43.00% | 120.69% | 1238.24% | -76.11% | Upgrade
|
| Other Receivables | 0.78 | 0.77 | 2.1 | 1.19 | 0.07 | 0.19 | Upgrade
|
| Receivables | 0.78 | 0.77 | 2.1 | 1.19 | 0.07 | 0.19 | Upgrade
|
| Prepaid Expenses | 0.21 | 0.18 | 0.35 | 0.77 | 0.13 | 0.17 | Upgrade
|
| Total Current Assets | 63.81 | 71.6 | 67.95 | 116.87 | 52.27 | 4.24 | Upgrade
|
| Property, Plant & Equipment | 0.37 | 0.26 | 0.69 | 0.5 | 0.59 | 1.15 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 0.16 | 0.18 | 0.13 | Upgrade
|
| Long-Term Deferred Charges | - | - | 0.58 | - | 0.35 | 0.83 | Upgrade
|
| Other Long-Term Assets | 0.87 | 0.97 | 1.14 | 0.38 | 0.98 | 1.1 | Upgrade
|
| Total Assets | 65.05 | 72.83 | 70.35 | 117.91 | 54.37 | 7.45 | Upgrade
|
| Accounts Payable | 5.95 | 6.47 | 5.66 | 4.19 | 2.72 | 4.57 | Upgrade
|
| Accrued Expenses | 9.05 | 5.96 | 5.15 | 5.37 | 2.75 | 3.44 | Upgrade
|
| Current Portion of Leases | 0.38 | 0.26 | 0.42 | 0.43 | 0.41 | 0.47 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 1.5 | - | Upgrade
|
| Total Current Liabilities | 16.09 | 12.68 | 11.23 | 9.99 | 7.37 | 8.49 | Upgrade
|
| Long-Term Leases | - | - | 0.26 | 0.04 | 0.14 | 0.55 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.2 | 0.16 | Upgrade
|
| Total Liabilities | 16.09 | 12.68 | 11.49 | 10.02 | 7.72 | 9.2 | Upgrade
|
| Common Stock | 0.04 | 0.03 | 0.01 | 0.09 | 0.06 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 500.85 | 459.59 | 376.9 | 371.64 | 270.16 | 193.32 | Upgrade
|
| Retained Earnings | -451.94 | -399.58 | -318.17 | -263.57 | -222.99 | -195.17 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.11 | 0.13 | -0.27 | -0.58 | 0.08 | Upgrade
|
| Total Common Equity | 48.95 | 60.14 | 58.87 | 107.89 | 46.65 | -1.75 | Upgrade
|
| Shareholders' Equity | 48.95 | 60.14 | 58.87 | 107.89 | 46.65 | -1.75 | Upgrade
|
| Total Liabilities & Equity | 65.05 | 72.83 | 70.35 | 117.91 | 54.37 | 7.45 | Upgrade
|
| Total Debt | 0.38 | 0.26 | 0.68 | 0.47 | 0.55 | 1.03 | Upgrade
|
| Net Cash (Debt) | 62.45 | 70.38 | 64.82 | 114.45 | 51.52 | 2.87 | Upgrade
|
| Net Cash Growth | -22.30% | 8.58% | -43.36% | 122.15% | 1698.22% | -82.41% | Upgrade
|
| Net Cash Per Share | 1.84 | 3.44 | 5.72 | 13.33 | 8.68 | 1.27 | Upgrade
|
| Filing Date Shares Outstanding | 38.32 | 25.6 | 11.88 | 8.83 | 5.97 | 3.58 | Upgrade
|
| Total Common Shares Outstanding | 38.26 | 25.57 | 9.9 | 8.83 | 5.97 | 2.42 | Upgrade
|
| Working Capital | 47.72 | 58.91 | 56.73 | 106.89 | 44.9 | -4.25 | Upgrade
|
| Book Value Per Share | 1.28 | 2.35 | 5.94 | 12.22 | 7.82 | -0.72 | Upgrade
|
| Tangible Book Value | 48.95 | 60.14 | 58.87 | 107.89 | 46.65 | -1.75 | Upgrade
|
| Tangible Book Value Per Share | 1.28 | 2.35 | 5.94 | 12.22 | 7.82 | -0.72 | Upgrade
|
| Machinery | - | 0.16 | 0.16 | 0.16 | 0.16 | 0.19 | Upgrade
|
| Leasehold Improvements | - | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.